Physician
New York Oncology Hematology, P.C.
New York Oncology Hematology, P.C. was paid $1.23M by Medicaid between Jan 2018 and Nov 2024, across 25 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 44% of everything it billed.
33Billing provider infoNEW YORK ONCOLOGY HEMATOLOGY, P.C.
ALBANY, NY 12206
ALBANY, NY 12206
33aNPI1609863448assigned 10/05/2005
33bProvider typeGynecologic Oncology Physician
28Total paid$1.23M
24GClaims84,192
24DCodes billed25
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Gynecologic Oncology Physician providers in New York
Rank by total paid#2 of 27
Median peer was paid$2K
This provider vs. median599×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,444 | $20K | |
| 2019 | 5,111 | $69K | |
| 2020 | 9,779 | $150K | |
| 2021 | 14,594 | $281K | |
| 2022 | 14,295 | $235K | |
| 2023 | 20,849 | $286K | |
| 2024incomplete | 17,120 | $190K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44% | 6,053 | 5,480 | $539K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16% | 30,784 | 27,147 | $196K |
| 80053 | Comprehensive metabolic panel | 16% | 21,685 | 19,173 | $192K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 2,410 | 2,349 | $159K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.6% | 345 | 267 | $32K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 530 | 459 | $26K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.8% | 160 | 149 | $22K |
| 83615 | 1.6% | 4,144 | 3,886 | $20K | |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | <1% | 256 | 102 | $11K |
| 82728 | <1% | 503 | 484 | $6K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 26 | 24 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,926 | 13,790 | $4K |
13 more codes
| 83550 | <1% | 397 | $3K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 25 | $3K |
| 96367 | <1% | 68 | $3K | |
| 83540 | <1% | 427 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 95 | $1K |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 31 | $897.24 |
| 83735 | <1% | 162 | $812.12 | |
| 82746 | <1% | 28 | $397.77 | |
| 82378 | <1% | 24 | $382.75 | |
| 82607 | <1% | 26 | $362.49 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 18 | $214.04 |
| 84550 | <1% | 56 | $183.88 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13 | $173.04 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOYLE, TODD (PRESIDENT)